ReviewBMB reports2018
BLT2, a leukotriene B4 receptor 2, as a novel prognostic biomarker of triple-negative breast cancer.
JaeIn Park et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papertrialcites it
ReviewBMB reports2018
JaeIn Park et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.